Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.81 |
| ▸ | ALPI | P09923 | 1/20 | 0.81 |
| ▸ | PKM | P14618 | 1/20 | 0.81 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.81 |
| ▸ | XIAP | P98170 | 1/20 | 0.81 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.58 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.58 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.58 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | LTA4H | P09960 | 1/20 | 0.54 |
| ▸ | SRR | Q9GZT4 | 2/20 | 0.52 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.51 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.50 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dl-Phenylalanine SCHEMBL31522545 | 1.00 | SLC7A5 (0.81) | SLC7A5ALPIPKMPTGS1XIAP | |
| Dl-Phenylalanine SCHEMBL20142619 | 1.00 | SLC7A5 (0.81) | SLC7A5ALPIPKMPTGS1XIAP | |
| Dl-Phenylalanine SCHEMBL1331077 | 0.90 | SLC7A5 (1.00) | SLC7A5ALPIPKMPTGS1XIAP | |
| Dl-Phenylalanine SCHEMBL288606 | 0.90 | SLC7A5 (1.00) | SLC7A5ALPIPKMPTGS1XIAP | |
| Dl-Phenylalanine SCHEMBL1332173 | 0.90 | SLC7A5 (1.00) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL23159186 | 0.90 | SLC7A5 (1.00) | SLC7A5ALPIPKMPTGS1XIAP | |
| Dl-Phenylalanine SCHEMBL1331829 | 0.90 | SLC7A5 (1.00) | SLC7A5ALPIPKMPTGS1XIAP | |
| Phenylalanine SCHEMBL8835931 | 0.90 | SLC7A5 (1.00) | SLC7A5ALPIPKMPTGS1XIAP | |
| Dl-Phenylalanine SCHEMBL2785094 | 0.90 | SLC7A5 (1.00) | SLC7A5ALPIPKMPTGS1XIAP | |
| Phenylalanine SCHEMBL1449128 | 0.90 | SLC7A5 (1.00) | SLC7A5ALPIPKMPTGS1XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4623937-A1 | ANTI-TUMOR COMPOUND AND USE THEREOF | Minghui Pharmaceutical (Hangzhou) Limited (CN) | 2025-10-01 | — | — | EP | claimed |
| WO-2024250985-A1 | TOLL-LIKE RECEPTOR AGONIST HETEROCYCLIC DERIVATIVE, PREPARATION THEREOF, AND USE THEREOF | 上海维申医药有限公司 | 2024-12-12 | — | — | WO | claimed |
| WO-2024250984-A1 | ANTIBODY-DRUG CONJUGATE, AND PHARMACEUTICAL COMPOSITION THEREOF, PREPARATION THEREFOR AND USE THEREOF | 上海维申医药有限公司 | 2024-12-12 | — | — | WO | claimed |
| WO-2024109949-A1 | ANTI-TUMOR COMPOUND AND USE THEREOF | 明慧医药（杭州）有限公司 | 2024-05-30 | — | — | WO | claimed |
| EP-4366777-A2 | LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME | PROFOUNDBIO US CO. (US) | 2024-05-15 | — | — | EP | claimed |
| CN-115028683-B | Pentapeptide compound and application thereof in preparation of medicines for treating liver fibrosis diseases | 陕西慧康生物科技有限责任公司 | 2024-05-14 | — | — | CN | claimed |
| CN-113698595-B | Polyselenoamino acid amphiphilic block copolymer targeting glucose transporter 1 and preparation method and application thereof | 深圳大学 | 2023-10-27 | — | — | CN | claimed |
| CN-115010918-B | Polyamino acid, preparation method thereof and nano vaccine | 中国科学院长春应用化学研究所 | 2023-10-13 | — | — | CN | claimed |
| EP-3768701-B1 | WNT SIGNALING AGONIST MOLECULES | UNIV BRUXELLES (BE) | 2023-08-02 | — | — | EP | claimed |
| US-20230128167-A1 | OLIGOPEPTIDE LINKER INTERMEDIATE AND PREPARATION METHOD THEREOF | MABPLEX INTERNATIONAL, LTD. (CN) | 2023-04-27 | — | — | US | claimed |
| WO-2023280227-A2 | LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME | PROFOUNDBIO US CO. (US) | 2023-01-12 | — | — | WO | claimed |
| CN-112442173-B | Polyseleno amino acid amphiphilic block copolymer, preparation method and application | 深圳大学 | 2022-12-20 | — | — | CN | claimed |
| CN-115028683-A | Pentapeptide compound and application thereof in preparation of medicine for treating hepatic fibrosis diseases | 陕西慧康生物科技有限责任公司 | 2022-09-09 | — | — | CN | claimed |
| CN-121405779-B | Polypeptide material for expelling solvent, preparation method thereof and application of polypeptide material in preparation of spherical propellant powder | 中国兵器工业火炸药工程与安全技术研究院 | 2026-05-15 | — | — | CN | disclosed |
| US-12570692-B2 | Oligopeptide linker intermediate and preparation method thereof | MABPLEX INTERNATIONAL CO., LTD. (CN) | 2026-03-10 | — | — | US | disclosed |
| EP-4623937-A1 | ANTI-TUMOR COMPOUND AND USE THEREOF | Minghui Pharmaceutical (Hangzhou) Limited (CN) | 2025-10-01 | — | — | EP | disclosed |
| WO-2022197819-A1 | SUNSCREENS DERIVED FROM KYNURENINES AND OTHER UV-ABSORBING OXIDIZED AMINO ACIDS BOUND TO PEPTIDES OR POLYMERS | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2022-09-22 | — | — | WO | disclosed |
| CN-115028683-A | Pentapeptide compound and application thereof in preparation of medicine for treating hepatic fibrosis diseases | 陕西慧康生物科技有限责任公司 | 2022-09-09 | — | — | CN | disclosed |
| CN-115028683-A | Pentapeptide compound and application thereof in preparation of medicine for treating hepatic fibrosis diseases | 陕西慧康生物科技有限责任公司 | 2022-09-09 | — | — | CN | disclosed |
| CN-112048001-B | Tumor neogenesis antigen polypeptide and application thereof | 南方科技大学 | 2022-04-05 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570692-B2 | Oligopeptide linker intermediate and preparation method thereof | VIP, AQP4, EPCAM | SLC7A5 554/4885ALPI 3196/4885PKM 1598/4885 |
| US-20230128167-A1 | OLIGOPEPTIDE LINKER INTERMEDIATE AND PREPARATION METHOD THEREOF | VIP, DNPEP, PREP | SLC7A5 2648/4885ALPI 831/4885PKM 1966/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.